AHA GUIDELINES Bundle (free trial)

High Blood Pressure - Merck Supported

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1539869

Contents of this Issue

Navigation

Page 70 of 87

71 Table 23. Antihypertensive Agents Used for Urgent Blood Pressure Control in Pregnancy Drug Dose Comments Onset of Action Labetalol 10–20 mg IV, then 20–80 mg every 10–30 min to a maximum cumulative dosage of 300 mg ; or constant infusion 1–3 mg/min IV Tachycardia is less common with fewer adverse effects. Avoid in women with asthma, preexisting myocardial disease, decompensated cardiac function, and heart block and bradycardia. 1–2 min Hydralazine 5 mg IV or IM, then 5–10 mg IV every 20–40 min to a maximum cumulative dosage of 20 mg ; or constant infusion of 0.5–10 mg/h Higher or frequent dosage associated with maternal hypotension, headaches, and abnormal fetal heart rate tracings; may be more common than other agents. 10–20 min Nifedipine (immediate release) 10–20 mg orally, repeat in 20 min if needed; then 10–20 mg every 2–6 h; maximum daily dose is 180 mg May observe reflex tachycardia and headaches. 5–10 min IM indicates intramuscular; and IV, intravenous. Reprinted with permission from American College of Obstetricians and Gynecologists. Copyright © 2020 American College of Obstetricians and Gynecologists.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - High Blood Pressure - Merck Supported